Allogene Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Allogene Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update
Allogene Therapeutics | 8-K/A: Current report (Amendment)
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update
Allogene Therapeutics | DEFA14A: Others
Allogene Therapeutics | DEF 14A: Definitive proxy statements
Allogene Therapeutics | 8-K: Current report
Allogene Therapeutics | 8-K: Current report
No Data